famotidine has been researched along with vasoactive intestinal peptide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inada, I; Satoh, H | 1 |
| Itoh, H; Naito, T; Takeyama, M | 1 |
1 trial(s) available for famotidine and vasoactive intestinal peptide
| Article | Year |
|---|---|
Effects of histamine H(2)-receptor antagonists on human plasma levels of calcitonin gene-related peptide, substance P and vasoactive intestinal peptide.
Topics: Adult; Calcitonin Gene-Related Peptide; Cimetidine; Famotidine; Histamine H2 Antagonists; Humans; Male; Nizatidine; Ranitidine; Substance P; Time Factors; Vasoactive Intestinal Peptide | 2002 |
1 other study(ies) available for famotidine and vasoactive intestinal peptide
| Article | Year |
|---|---|
Capsaicin-sensitive sensory neurons are involved in bicarbonate secretion induced by lansoprazole, a proton pump inhibitor, in rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Bicarbonates; Capsaicin; Duodenum; Famotidine; Histamine H2 Antagonists; Intestinal Mucosa; Lansoprazole; Male; Neurons, Afferent; Omeprazole; Proton Pump Inhibitors; Rats; Rats, Sprague-Dawley; Stimulation, Chemical; Vasoactive Intestinal Peptide | 1996 |